🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The primary objective of this study is to determine if the combination regi...
Status
Terminated
Location
Multiple Locations
Start Date
2011-07
Trial ID
NCT01377376
Treatments Being Tested
This study is a Phase I/II trial of Tivantinib plus FOLFOX for the treatmen...
Status
Completed
Location
Yale University School of Medicine
Start Date
2012-07
Trial ID
NCT01611857
Treatments Being Tested
This randomized phase II trial studies how well tivantinib works compared t...
Status
Completed
Location
MedStar Georgetown University Hospital
Start Date
2012-01-11
Trial ID
NCT01519414
Treatments Being Tested
This is a Phase 1, randomized, open label, 2 treatment, 2 period, 2-way cro...
Status
Completed
Location
Premiere Oncology
Start Date
2010-07
Trial ID
NCT01149720
Treatments Being Tested
The primary objective of this study is to examine if the combination regime...
Status
Completed
Location
Multiple Locations
Start Date
2012-05
Trial ID
NCT01580735
Treatments Being Tested
This phase II trial studies how well tivantinib works in treating patients ...
Status
Terminated
Location
City of Hope Comprehensive Cancer Center
Start Date
2013-01
Trial ID
NCT01861301
Treatments Being Tested
This study aims to assess the role of MET inhibitors as maintenance treatme...
Status
Terminated
Location
Istituto Oncologico Veneto
Start Date
2016-02-19
Trial ID
NCT02608411
Treatments Being Tested
This is a multicenter, single-arm study for safety and efficacy....
Status
Terminated
Location
Multiple Locations
Start Date
2010-02-02
Trial ID
NCT01055067
Treatments Being Tested
The purpose of this study is to determine if tivantinib (ARQ 197) is effect...
Status
Completed
Location
Multiple Locations
Start Date
2012-12-27
Trial ID
NCT01755767
Treatments Being Tested
A phase II open-label study with ARQ 197 administered orally and twice dail...
Status
Completed
Location
Multiple Locations
Start Date
2010-06
Trial ID
NCT01152645
Treatments Being Tested